Adrian Gottschalk

2023

In 2023, Adrian Gottschalk earned a total compensation of $2.5M as President and Chief Executive Officer at Foghorn Therapeutics, a 54% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$202,650
Option Awards$1,719,292
Salary$579,000
Other$3,000
Total$2,503,942

Gottschalk received $1.7M in option awards, accounting for 69% of the total pay in 2023.

Gottschalk also received $202.7K in non-equity incentive plan, $579K in salary and $3K in other compensation.

Rankings

In 2023, Adrian Gottschalk's compensation ranked 389th out of 2,918 executives tracked by ExecPay. In other words, Gottschalk earned more than 86.7% of executives.

ClassificationRankingPercentile
All
389
out of 2,918
87th
Division
Manufacturing
224
out of 1,608
86th
Major group
Chemicals And Allied Products
157
out of 901
83rd
Industry group
Drugs
154
out of 864
82nd
Industry
Pharmaceutical Preparations
94
out of 622
85th
Source: SEC filing on May 3, 2024.

Gottschalk's colleagues

We found two more compensation records of executives who worked with Adrian Gottschalk at Foghorn Therapeutics in 2023.

2023

Alfonso Quintás-Cardama

Foghorn Therapeutics

Chief Medical Officer

2023

Steven Bellon

Foghorn Therapeutics

Chief Scientific Officer

News

In-depth

You may also like